Concepedia

James Black

JB

4

Publications

826

Citations

4

H-Index

1999

Active since

Affiliations

Vertex Pharmaceuticals (United States)(Current)

James Black is an author at Vertex Pharmaceuticals (United States) specializing in biochemistry, cell signaling, and drug discovery.

Top concepts

Publications per year

1999–2015

4

Publications

4

The Structural Basis for Autoinhibition of FLT3 by the Juxtamembrane Domain

James Griffith, James Black, Carlos H. Faerman et al. · Molecular Cell · 2004 · 495 citations · Full text

, , +7

Pim-1 Ligand-bound Structures Reveal the Mechanism of Serine/Threonine Kinase Inhibition by LY294002

Marc Jacobs, James Black, Olga Futer et al. · Journal of Biological Chemistry · 2005 · 186 citations · Full text

Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases

Luc J. Farmer, Mark W. Ledeboer, Thomas Hoock et al. · Journal of Medicinal Chemistry · 2015 · 87 citations

, , +16

Biochemical Analysis of the Modular Enzyme Inosine 5′-Monophosphate Dehydrogenase

Elmar Nimmesgern, James Black, Olga Futer et al. · Protein Expression and Purification · 1999 · 58 citations

, ,

Rows per page

1–4 of 4